When is Trufin's general meeting to approve the tender offer scheduled?

Trufin's general meeting to approve the tender offer is scheduled for 10:00 a.m. on 27 July 2026.

Trufin — TickStock

Timeline

Trufin

1 stories · updated 9 Jul

TruFin plans £80m return of capital after Playstack sale

09:27, 9 Jul 2026

More in Private Equity & VC

The image captures a close-up view of ocean waves, highlighting droplets of water splashing as they crash against the surface. The shimmering reflections create a dynamic and captivating visual of the natural water environment.

Transport & Logistics

Tekcapital's Guident signs three-year robotics deal with Coastal Waste

Guident, a Tekcapital portfolio company, has expanded its partnership with Coastal Waste & Recycling into a 36-month agreement covering autonomous inspection robots and AI monitoring software.

07:40, 21 Aug 2026

Renewables & Clean Energy

Vesari adds satellite networking expert to science board

08:27, 20 Aug 2026

AI & Machine Learning

Small Caps Today: Nostrum, Graphwise, Alesta Therapeutics, Nanoco, Cooks Coffee, Ultimate Products

13:33, 19 Aug 2026

Biotech

BioMarin to acquire RTW Bio portfolio company Alesta

08:11, 19 Aug 2026

Private Equity & VC

Oakley Capital's backs AI data platform Graphwise

08:06, 19 Aug 2026

Renewables & Clean Energy

Tekcapital's Vesari files twelfth US patent application

07:51, 19 Aug 2026

Healthcare Services

HgCapital Trust backs £20m Nourish investment

07:42, 18 Aug 2026

Private Equity & VC

Robinhood's second venture fund starts trading on NYSE

10:31, 14 Aug 2026

Asset Management

Georgia Capital launches $50m buyback after completing prior programme

08:28, 14 Aug 2026

Biotech

Avere Therapeutics to go public via NextCure reverse merger

09:08, 12 Aug 2026

Biotech

Syncona highlights upcoming catalysts as trial advances

09:41, 6 Aug 2026

TruFin is an AIM-listed platform business acquirer that buys, holds and grows specialist businesses and their bolt-on acquisitions. It actively manages subsidiaries to drive shareholder value.

Sector: Private Equity & VC
Market: AIM

Insight

When did TruFin sell Playstack and for how much did it net?

TruFin sold Playstack on 10 June 2026 for net proceeds of £112.4m, subject to a £1.5m holdback, and returned £80.0m to shareholders.

Updated 9 Jul 2026

Insight

What board appointment right will major shareholder Gresham receive under TruFin's proposed relationship agreement?

TruFin said the relationship agreement will give major shareholder Gresham the right to appoint a director to TruFin's board while Gresham maintains a holding above 15%.

Updated 9 Jul 2026

Insight

How much unrestricted cash does TruFin expect to retain after the Playstack sale?

TruFin expects to retain about £24.0m of unrestricted cash after incentive payments of £7.9m and employer national insurance, with plans to deploy it within twelve months.

Updated 9 Jul 2026

Insight

What are TruFin's profit expectations for 2026 and 2027?

TruFin is forecast to remain loss-making in 2026 and targets profitability in 2027.

Updated 9 Jul 2026

Insight

How much is TruFin returning to shareholders and by what methods?

TruFin's board is returning £80m to shareholders via a tender offer and a dividend.

Updated 9 Jul 2026

Identifiers

Ticker: TRU
Market: AIM
ISIN: JE00BYVWJZ03
LEI: 7C637250473973575045

Learn more on:

GLEIF

Timeline

Trufin

TruFin plans £80m return of capital after Playstack sale

More in Private Equity & VC

Tekcapital's Guident signs three-year robotics deal with Coastal Waste

Vesari adds satellite networking expert to science board

Small Caps Today: Nostrum, Graphwise, Alesta Therapeutics, Nanoco, Cooks Coffee, Ultimate Products

BioMarin to acquire RTW Bio portfolio company Alesta

Oakley Capital's backs AI data platform Graphwise

Tekcapital's Vesari files twelfth US patent application

HgCapital Trust backs £20m Nourish investment

Robinhood's second venture fund starts trading on NYSE

Georgia Capital launches $50m buyback after completing prior programme

Avere Therapeutics to go public via NextCure reverse merger

Syncona highlights upcoming catalysts as trial advances

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer